Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure. (25th May 2022)

• Record Type: Journal Article
• Authors: Luo, Jing‐chao; Zhang, Yi‐Jie; Huang, Dan‐lei; Wang, Huan; Luo, Ming‐hao; Hou, Jun‐yi; Hao, Guang‐wei; Su, Ying; Tu, Guo‐wei; Luo, Zhe
• Is Part Of: ESC heart failure. Volume 9:Number 4(2022)
• Page Start: 2635
• Page End: 2644
• Publication Date: 2022-05-25
• Subjects: rh‐BNP -- Venous return -- Cardiac output -- Congestive heart failure; Heart failure -- Periodicals; 616.129005
• DOI: 10.1002/ehf2.13987
• Languages: English
• ISSNs: 2055-5822

Abstract

Abstract: Aims: Recombinant human brain natriuretic peptide (rh‐BNP) is commonly used as a decongestive therapy. This study aimed to investigate the instant effects of rh‐BNP on cardiac output and venous return function in post‐cardiotomy patients with congestive heart failure (CHF). Methods and results: Twenty‐four post‐cardiotomy heart failure patients were enrolled and received a standard loading dose of rh‐BNP. Haemodynamic monitoring was performed via a pulmonary artery catheter before and after the administration of rh‐BNP. The cardiac output and venous return functions were estimated by depicting Frank‐Starling and Guyton curves. After rh‐BNP infusion, variables reflecting cardiac congestion and venous return function, such as pulmonary artery wedge pressure, mean systemic filling pressure (Pmsf) and venous return resistance index (VRRI), reduced from 15 ± 3 to 13 ± 3 mmHg, from 32 ± 7 to 28 ± 7 mmHg and from 6.7 ± 2.6 to 5.7 ± 1.8 mmHg min m 2 /L, respectively. Meanwhile, cardiac index, stroke volume index, and the cardiac output function curve remained unchanged per se. The decline in Pmsf [−13% (−22% to −8%)] and VRRI [−12% (−25% to −5%)] was much greater than that in the systemic vascular resistance index [−7% (−14% to 0%)]. In the subgroup analysis of reduced ejection fraction (<40%) patients, the aforementioned changes were more significant. Conclusions: rh‐BNP might ameliorate venous return rather than cardiac output function in post‐cardiotomy CHF patients.